SLC35D4
gene geneOn this page
Also known as MGC11386FLJ44259
Summary
SLC35D4 (solute carrier family 35 member D4, HGNC:31723) is a protein-coding gene on chromosome 18q11.2, encoding UDP-N-acetylglucosamine transporter SLC35D4 (Q24JQ0). Golgi-localized UDP-N-acetylglucosamine (UDP-GlcNAc) transporter that transports UDP-N-acetylglucosamine into Golgi lumen.
Enables UDP-N-acetylglucosamine transmembrane transporter activity. Involved in UDP-N-acetylglucosamine transmembrane transport. Located in Golgi apparatus.
Source: NCBI Gene 85019 — RefSeq curated summary.
At a glance
- GWAS associations: 19
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_032933
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31723 |
| Approved symbol | SLC35D4 |
| Name | solute carrier family 35 member D4 |
| Location | 18q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC11386, FLJ44259 |
| Ensembl gene | ENSG00000134490 |
| Ensembl biotype | protein_coding |
| OMIM | 615430 |
| Entrez | 85019 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 14 protein_coding, 8 nonsense_mediated_decay, 4 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000383233, ENST00000460322, ENST00000473688, ENST00000475185, ENST00000477053, ENST00000482411, ENST00000497608, ENST00000542162, ENST00000577448, ENST00000577531, ENST00000578520, ENST00000578790, ENST00000580025, ENST00000581444, ENST00000582336, ENST00000583048, ENST00000584625, ENST00000907352, ENST00000907353, ENST00000907354, ENST00000907355, ENST00000938582, ENST00000938583, ENST00000938584, ENST00000938585, ENST00000951849, ENST00000951850
RefSeq mRNA: 2 — MANE Select: NM_032933
NM_001318834, NM_032933
CCDS: CCDS11876
Canonical transcript exons
ENST00000383233 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002168027 | 23437781 | 23437961 |
| ENSE00003460372 | 23370216 | 23370261 |
| ENSE00003461713 | 23365634 | 23365668 |
| ENSE00003467343 | 23356594 | 23356663 |
| ENSE00003470822 | 23373712 | 23373763 |
| ENSE00003548097 | 23384990 | 23385067 |
| ENSE00003560190 | 23371422 | 23371470 |
| ENSE00003560952 | 23421367 | 23421444 |
| ENSE00003561927 | 23399566 | 23399647 |
| ENSE00003569476 | 23352196 | 23352289 |
| ENSE00003603005 | 23309680 | 23309744 |
| ENSE00003623398 | 23296013 | 23298067 |
| ENSE00003645626 | 23430631 | 23430677 |
| ENSE00003683251 | 23368715 | 23368750 |
| ENSE00003694704 | 23377646 | 23377671 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 99.77.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.5568 / max 54.1666, expressed in 1704 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 171350 | 5.4147 | 1691 |
| 171346 | 0.0671 | 39 |
| 171347 | 0.0406 | 23 |
| 171349 | 0.0279 | 12 |
| 171348 | 0.0064 | 3 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 99.77 | gold quality |
| pancreatic ductal cell | CL:0002079 | 97.61 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 97.58 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 96.81 | gold quality |
| upper arm skin | UBERON:0004263 | 96.55 | gold quality |
| kidney epithelium | UBERON:0004819 | 96.13 | gold quality |
| medial globus pallidus | UBERON:0002477 | 95.65 | gold quality |
| tibialis anterior | UBERON:0001385 | 94.98 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 94.57 | silver quality |
| ileal mucosa | UBERON:0000331 | 94.24 | gold quality |
| globus pallidus | UBERON:0001875 | 94.21 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 93.89 | silver quality |
| upper leg skin | UBERON:0004262 | 93.73 | gold quality |
| oviduct epithelium | UBERON:0004804 | 93.62 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 92.94 | gold quality |
| myocardium | UBERON:0002349 | 92.83 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 92.50 | gold quality |
| mammary duct | UBERON:0001765 | 92.46 | gold quality |
| cerebellar vermis | UBERON:0004720 | 92.24 | gold quality |
| deltoid | UBERON:0001476 | 91.09 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 91.02 | gold quality |
| vena cava | UBERON:0004087 | 90.89 | gold quality |
| quadriceps femoris | UBERON:0001377 | 90.86 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 90.77 | gold quality |
| cardia of stomach | UBERON:0001162 | 90.63 | gold quality |
| biceps brachii | UBERON:0001507 | 90.49 | gold quality |
| vastus lateralis | UBERON:0001379 | 90.40 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 90.35 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 90.35 | gold quality |
| ventral tegmental area | UBERON:0002691 | 89.82 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.73 |
| E-MTAB-7606 | no | 21.72 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
85 targeting SLC35D4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-379-3P | 99.69 | 69.60 | 1524 |
| HSA-MIR-411-3P | 99.69 | 69.63 | 1524 |
Literature-anchored findings (GeneRIF, showing 1)
- The Mexican genome-wide association study signal for high serum triglycerides on chromosome 18q11.2 harbors a regulatory single-nucleotide polymorphism, rs17259126, which disrupts normal hepatocyte nuclear factor 4 alpha binding and decreases the expression of the regional TMEM241 gene. Our data suggest that decreased transcript levels of TMEM241 contribute to increased triglyceride levels in Mexicans. (PMID:27199446)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem241 | ENSDARG00000090685 |
| ENSDARG00000104905 | ||
| mus_musculus | Tmem241 | ENSMUSG00000049411 |
| rattus_norvegicus | Tmem241 | ENSRNOG00000023412 |
| drosophila_melanogaster | frc | FBGN0042641 |
| caenorhabditis_elegans | WBGENE00005025 |
Paralogs (9): SLC35C2 (ENSG00000080189), SLC35E4 (ENSG00000100036), SLC35D1 (ENSG00000116704), SLC35E1 (ENSG00000127526), SLC35D2 (ENSG00000130958), SLC35E3 (ENSG00000175782), SLC35C1 (ENSG00000181830), SLC35D3 (ENSG00000182747), SLC35E2B (ENSG00000189339)
Protein
Protein identifiers
UDP-N-acetylglucosamine transporter SLC35D4 — Q24JQ0 (reviewed: Q24JQ0)
Alternative names: Solute carrier family 35 member D4, Transmembrane protein 241
All UniProt accessions (8): E9PJC2, E9PLG4, Q24JQ0, F5GXY7, H0YDH1, J3QL29, J3QR22, J3QRE6
UniProt curated annotations — full annotation on UniProt →
Function. Golgi-localized UDP-N-acetylglucosamine (UDP-GlcNAc) transporter that transports UDP-N-acetylglucosamine into Golgi lumen. Contributes to lysosomal targeting of NPC2, a key protein required for lysosomal cholesterol exiting, and that utilizes the mannose-6-phosphate (M6P) modification pathway for its lysosomal targeting.
Subcellular location. Golgi apparatus. cis-Golgi network membrane.
Induction. Up-regulated by inducers of the unfolded protein response (UPR), including tunicamycin and thapsigargin.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the nucleotide-sugar transporter family. SLC35D subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q24JQ0-1 | 1 | yes |
| Q24JQ0-2 | 2 | |
| Q24JQ0-3 | 3 |
RefSeq proteins (2): NP_001305763, NP_116322* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR050186 | TPT_transporter | Family |
UniProt features (17 total): transmembrane region 10, splice variant 5, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q24JQ0-F1 | 94.11 | 0.86 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 88 (showing top):
GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT, GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, chr18q11, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, LIU_COMMON_CANCER_GENES, GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
GO Biological Process (2): UDP-N-acetylglucosamine transmembrane transport (GO:1990569), GDP-mannose transmembrane transport (GO:1990570)
GO Molecular Function (4): GDP-mannose transmembrane transporter activity (GO:0005458), UDP-N-acetylglucosamine transmembrane transporter activity (GO:0005462), antiporter activity (GO:0015297), protein binding (GO:0005515)
GO Cellular Component (2): Golgi apparatus (GO:0005794), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| pyrimidine nucleotide-sugar transmembrane transport | 1 |
| purine nucleotide-sugar transmembrane transport | 1 |
| purine nucleotide-sugar transmembrane transporter activity | 1 |
| GDP-mannose transmembrane transport | 1 |
| pyrimidine nucleotide-sugar transmembrane transporter activity | 1 |
| UDP-N-acetylglucosamine transmembrane transport | 1 |
| secondary active transmembrane transporter activity | 1 |
| binding | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
658 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC35D4 | ANKRD29 | Q8N6D5 | 527 |
| SLC35D4 | CABLES1 | Q8TDN4 | 480 |
| SLC35D4 | CDH22 | Q9UJ99 | 460 |
| SLC35D4 | FAM53A | Q6NSI3 | 459 |
| SLC35D4 | GREB1L | Q9C091 | 456 |
| SLC35D4 | THOC1 | Q96FV9 | 420 |
| SLC35D4 | ZNF587B | E7ETH6 | 417 |
| SLC35D4 | TMEM169 | Q96HH4 | 403 |
| SLC35D4 | ZNF521 | Q96K83 | 401 |
| SLC35D4 | CHST11 | Q9NPF2 | 375 |
| SLC35D4 | MRPL21 | Q7Z2W9 | 365 |
| SLC35D4 | TIGD6 | Q17RP2 | 359 |
| SLC35D4 | MYSM1 | Q5VVJ2 | 353 |
| SLC35D4 | PHTF2 | Q8N3S3 | 347 |
| SLC35D4 | MINDY4 | Q4G0A6 | 330 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STX7 | TMEM241 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM241 | LZTFL1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TMEM241 | FAAH | psi-mi:“MI:0914”(association) | 0.350 |
| STX7 | TMEM241 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (73): KRT40 (Two-hybrid), TMEM241 (Two-hybrid), TMEM241 (Affinity Capture-RNA), TMEM241 (Synthetic Lethality), TMEM241 (Two-hybrid), LZTFL1 (Affinity Capture-MS), AAAS (Affinity Capture-MS), ACBD5 (Affinity Capture-MS), ADPGK (Affinity Capture-MS), ALG10 (Affinity Capture-MS), AMFR (Affinity Capture-MS), ANKLE2 (Affinity Capture-MS), ANO10 (Affinity Capture-MS), ANO8 (Affinity Capture-MS), ATP13A1 (Affinity Capture-MS)
ESM2 similar proteins: A0A084AFH0, A1L3G4, A1Z7R6, A5WWC6, A7YW81, B0B8F4, B0K004, D3YVE8, O04508, O74750, O84584, P0C7Q5, P0C7Q6, P39542, P40004, P53403, Q00974, Q0Q7U7, Q0Q7U8, Q0Q7U9, Q0Q7V0, Q0V9U2, Q1PFJ4, Q23444, Q24JQ0, Q3UME2, Q5F297, Q5M7A3, Q5PT55, Q5ZJZ4, Q7RTP0, Q8BHK1, Q8MXJ9, Q8N808, Q94EI9, Q96KT7, Q9C508, Q9C654, Q9C8M1, Q9FG70
Diamond homologs: A1C9R4, A1CZJ3, A1DA52, A1L3G4, A2R9P4, A3LWX1, A4RM13, A5DIN8, A6RJQ8, A6ZQY8, A6ZTW6, A7E558, A7TES5, A7TR80, A8N9T6, A8PTV6, B0DI84, B0Y384, B3LHR7, B3LS51, B3LS52, B5VHH5, C7GSI5, C7GSI6, C7GUZ7, C8Z742, C8Z830, P0CD97, P0CE11, P0CS02, P0CS03, P0CS04, P0CS05, P40107, Q0CA27, Q0UG89, Q1DTI4, Q24JQ0, Q2AAF6, Q2HA88
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4431 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:23213976:GAATA:G | acceptor_gain | 1.0000 |
| 18:23237130:T:G | acceptor_gain | 1.0000 |
| 18:23252948:T:TA | acceptor_gain | 1.0000 |
| 18:23252952:T:TA | acceptor_gain | 1.0000 |
| 18:23252958:A:AG | acceptor_gain | 1.0000 |
| 18:23252958:A:G | acceptor_loss | 1.0000 |
| 18:23252959:G:GA | acceptor_gain | 1.0000 |
| 18:23252959:GA:G | acceptor_gain | 1.0000 |
| 18:23252959:GAC:G | acceptor_gain | 1.0000 |
| 18:23252959:GACA:G | acceptor_gain | 1.0000 |
| 18:23252959:GACAA:G | acceptor_gain | 1.0000 |
| 18:23253025:G:GT | donor_gain | 1.0000 |
| 18:23253063:GGAG:G | donor_gain | 1.0000 |
| 18:23253064:GAG:G | donor_gain | 1.0000 |
| 18:23253064:GAGG:G | donor_gain | 1.0000 |
| 18:23253065:AGG:A | donor_loss | 1.0000 |
| 18:23253067:GT:G | donor_loss | 1.0000 |
| 18:23253068:T:G | donor_loss | 1.0000 |
| 18:23253716:T:A | acceptor_gain | 1.0000 |
| 18:23253727:A:AG | acceptor_gain | 1.0000 |
| 18:23253727:AGTCT:A | acceptor_gain | 1.0000 |
| 18:23253728:G:GA | acceptor_gain | 1.0000 |
| 18:23253728:GT:G | acceptor_gain | 1.0000 |
| 18:23253728:GTC:G | acceptor_gain | 1.0000 |
| 18:23253728:GTCT:G | acceptor_gain | 1.0000 |
| 18:23253728:GTCTG:G | acceptor_gain | 1.0000 |
| 18:23253852:G:GT | donor_gain | 1.0000 |
| 18:23253896:G:GT | donor_gain | 1.0000 |
| 18:23253916:G:GT | donor_gain | 1.0000 |
| 18:23253932:TTGAC:T | donor_gain | 1.0000 |
AlphaMissense
1914 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:23430654:A:C | F32L | 0.993 |
| 18:23430654:A:T | F32L | 0.993 |
| 18:23430656:A:G | F32L | 0.993 |
| 18:23365668:A:C | S189R | 0.990 |
| 18:23365668:A:T | S189R | 0.990 |
| 18:23368716:T:G | S189R | 0.990 |
| 18:23352289:A:C | S224R | 0.989 |
| 18:23352289:A:T | S224R | 0.989 |
| 18:23356595:T:G | S224R | 0.989 |
| 18:23356614:G:C | F217L | 0.989 |
| 18:23356614:G:T | F217L | 0.989 |
| 18:23356616:A:G | F217L | 0.989 |
| 18:23421443:A:G | W41R | 0.989 |
| 18:23421443:A:T | W41R | 0.989 |
| 18:23430655:A:G | F32S | 0.989 |
| 18:23430655:A:C | F32C | 0.974 |
| 18:23356615:A:G | F217S | 0.973 |
| 18:23385053:A:C | F98L | 0.973 |
| 18:23385053:A:T | F98L | 0.973 |
| 18:23385055:A:G | F98L | 0.973 |
| 18:23356638:G:C | F209L | 0.970 |
| 18:23356638:G:T | F209L | 0.970 |
| 18:23356640:A:G | F209L | 0.970 |
| 18:23430632:C:G | G40R | 0.969 |
| 18:23430632:C:T | G40R | 0.969 |
| 18:23356605:G:C | S220R | 0.966 |
| 18:23356605:G:T | S220R | 0.966 |
| 18:23356607:T:G | S220R | 0.966 |
| 18:23437781:C:A | K24N | 0.965 |
| 18:23437781:C:G | K24N | 0.965 |
dbSNP variants (sampled 300 via entrez): RS1000002065 (18:23342644 C>A,T), RS1000034644 (18:23387598 T>C), RS1000057030 (18:23302151 C>T), RS1000069960 (18:23289606 C>A), RS1000070076 (18:23432558 G>A), RS1000103356 (18:23395941 G>A,C), RS1000124583 (18:23292927 G>A), RS1000127176 (18:23375413 G>A), RS1000133014 (18:23434759 A>C,G), RS1000149043 (18:23317548 C>T), RS1000202976 (18:23382164 C>T), RS1000203448 (18:23344209 G>A), RS1000205672 (18:23322536 T>G), RS1000223493 (18:23336991 A>G), RS1000225182 (18:23414612 G>A)
Disease associations
OMIM: gene MIM:615430 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
19 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000175_6 | Height | 4.000000e-09 |
| GCST001905_6 | Hypertriglyceridemia | 2.000000e-08 |
| GCST003474_9 | Scalp hair shape | 6.000000e-06 |
| GCST006946_17 | Worry too long after an embarrassing experience | 2.000000e-08 |
| GCST008152_177 | Weight | 8.000000e-06 |
| GCST008163_417 | Height | 2.000000e-06 |
| GCST008163_493 | Height | 1.000000e-06 |
| GCST008181_19 | Spontaneous preterm birth without premature rupture of membranes | 1.000000e-06 |
| GCST010139_1 | Poultry consumption | 1.000000e-09 |
| GCST012226_134 | Waist circumference adjusted for body mass index | 9.000000e-09 |
| GCST012226_135 | Waist circumference adjusted for body mass index | 3.000000e-10 |
| GCST012226_136 | Waist circumference adjusted for body mass index | 2.000000e-12 |
| GCST012227_710 | Hip circumference adjusted for BMI | 6.000000e-11 |
| GCST90020028_1302 | Hip circumference adjusted for BMI | 7.000000e-11 |
| GCST90020028_1303 | Hip circumference adjusted for BMI | 2.000000e-16 |
| GCST90020028_1304 | Hip circumference adjusted for BMI | 3.000000e-10 |
| GCST90020029_6 | Waist circumference adjusted for body mass index | 2.000000e-08 |
| GCST90020029_7 | Waist circumference adjusted for body mass index | 6.000000e-18 |
| GCST90020029_8 | Waist circumference adjusted for body mass index | 6.000000e-11 |
EFO canonical traits (7, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004530 | triglyceride measurement |
| EFO:0009589 | worry measurement |
| EFO:0004338 | body weight |
| EFO:0006917 | spontaneous preterm birth |
| EFO:0008111 | diet measurement |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 2 |
| Air Pollutants | increases abundance, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Particulate Matter | increases abundance, increases expression | 2 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Temozolomide | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Estradiol | increases expression | 1 |
| Malathion | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Urethane | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4RA | HCT116-TMEM241-KO-c3 | Cancer cell line | Male |
| CVCL_D4RB | HCT116-TMEM241-KO-c4 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.